Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016)
Tonix Pharmaceuticals Holding (TNXP) posted Deferred Taxes of -$9000.0 for Q1 2016, down 120.0% on a QoQ basis from $45000.0 in Q4 2015, and down 350.0% year-over-year from $3600.0 in Q2 2015.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Deferred Taxes for 6 years, with the latest figure at -$9000.0 in Q1 2016.
- On a quarterly basis, Deferred Taxes fell 350.0% year-over-year to -$9000.0 in Q1 2016; TTM through Mar 2016 was $47000.0, a 14.55% decrease from a year earlier, with the FY2015 full-year figure at $54000.0, down 1.82% from the prior year.
- Deferred Taxes was -$9000.0 for Q1 2016 at Tonix Pharmaceuticals Holding, down from $45000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $47000.0 in Q3 2014, with the low at -$9000.0 in Q1 2016.
- Average Deferred Taxes over 5 years is $5294.1, with a median of -$1000.0 recorded in 2013.
- The sharpest annual moves came in 2014 and 2016: Deferred Taxes jumped 4800.0% in 2014, then slumped 350.0% in 2016.
- Over 5 years, Deferred Taxes stood at -$1460.0 in 2012, then plunged by 105.48% to -$3000.0 in 2013, then surged by 400.0% to $9000.0 in 2014, then surged by 400.0% to $45000.0 in 2015, then slumped by 120.0% to -$9000.0 in 2016.
- The last three Deferred Taxes figures came in at -$9000.0 (Q1 2016), $45000.0 (Q4 2015), and $12000.0 (Q3 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -1.32 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 115.62 Mn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | -9,000.00 |
| Dec 31, 2015 | 45,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | -1,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 47,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Mar 31, 2014 | -2,000.00 |
| Dec 31, 2013 | -3,000.00 |
| Sep 30, 2013 | -1,000.00 |
| Jun 30, 2013 | -2,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Dec 31, 2012 | -1,460.00 |
| Sep 30, 2012 | -513.00 |
| Jun 30, 2012 | -514.00 |
| Mar 31, 2012 | -513.00 |
| Dec 31, 2011 | -514.00 |
| Sep 30, 2011 | 334.00 |
| Jun 30, 2011 | 334.00 |